Development and validation of cryopreserved or freeze-dried decellularized human dermis for transplantation

Giulia Montagner,Antonia Barbazza,Manvi Pant,Andrea Tancredi Lugas,Gianpaolo Serino,Cristina Bignardi,Mara Terzini,Andrea Vantini,Jacopo Stefanelli,Diletta Trojan
DOI: https://doi.org/10.1007/s10561-024-10131-6
2024-02-22
Cell and Tissue Banking
Abstract:For decades, dermal tissue grafts have been used in various regenerative, reconstructive, and augmentative procedures across the body. To eliminate antigenicity and immunogenic response while still preserving the individual components and collective structural integrity of the extracellular matrix (ECM), dermis can be decellularized. Acellular dermal matrix (ADM) products like such are produced to accurately serve diverse clinical purposes. The aim of the present study is to evaluate the efficacy of a novel decellularization protocol of the human dermis, which eliminates residual human genetic material without compromising the biomechanical integrity and collagenous content of the tissue. Moreover, a freeze-drying protocol was validated. The results showed that though our decellularization protocol, human dermis can be decellularized obtaining a biocompatible matrix. The procedure is completely realized in GMP aseptic condition, avoiding tissue terminal sterilization.
engineering, biomedical,cell biology
What problem does this paper attempt to address?